coronavirus
cov
group
positivesens
singlestrand
rna
virus
respons
agricultur
human
diseas
high
econom
burden
outbreak
potenti
understand
pathway
drive
cov
replic
pathogenesi
crucial
combat
cov
high
mortal
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
cov
mous
hepat
viru
mhv
prototyp
cov
caus
hepat
andor
enceph
depend
strain
previou
studi
detail
mani
cellular
pathway
critic
elicit
mhv
infect
sever
antivir
mechan
induc
mhv
infect
mhv
encod
protein
counter
host
process
instanc
interferon
ifn
especi
type
ifn
ifni
vital
limit
mhv
infect
mice
ifni
product
signal
inhibit
mhv
infect
multipl
cell
type
mhv
also
inhibit
function
downstream
ifnstimul
gene
isg
exampl
mhv
macrodomain
virusencod
adpribosylhydrolas
revers
cellular
adp
ribosyl
ifniinduc
poli
adpribos
polymeras
parp
limit
viral
replic
aryl
hydrocarbon
receptor
ahr
receptortranscript
factor
shown
direct
multipl
host
respons
initi
believ
oper
context
cellular
respons
toxin
ahr
recogn
signific
regul
host
immun
respons
well
ahr
cytosol
activ
bind
ligand
exogen
toxin
tcdd
endogen
cellular
metabolit
fig
trigger
ahr
transloc
nucleu
ahr
complex
ahr
nuclear
transloc
arnt
bind
partner
induc
express
sever
differ
protein
downstream
effector
respons
degrad
xenobiot
agent
limit
potenti
cellular
damag
upregul
gene
includ
encod
cytochrom
enzym
cyp
catabol
exotoxin
neg
regul
ahr
activ
deplet
ahr
ligand
anoth
inhibitori
protein
ahr
repressor
ahrr
also
upregul
compet
arnt
ahr
dimer
nucleu
also
known
tcddinduc
parp
tiparp
highli
induc
ahr
activ
well
indic
relationship
cellular
adp
ribosyl
tiparp
respons
mitig
patholog
tcdd
administr
mice
least
part
due
feedback
inhibit
ahr
context
immun
respons
endogen
metabolit
like
primari
ligand
drive
ahr
activ
prototyp
endogen
ligand
kynurenin
tryptophan
catabolit
produc
indoleamin
immun
cell
tryptophan
tdo
encod
gene
liver
best
character
enzym
induc
inflammatori
factor
ifni
ifnii
transform
growth
factor
beta
interleukin
ahr
also
activ
express
enhanc
activ
multipl
pathway
result
positivefeedback
loop
prolong
effect
ahr
activ
though
kynurenin
believ
predomin
deriv
tryptophan
drive
ahr
activ
multipl
degrad
product
tryptophan
biomolecul
synthes
independ
tdo
sourc
gut
microflora
diet
even
uvmedi
photooxid
prostaglandin
cyclic
amp
camp
oxid
speci
may
also
activ
ahr
though
unknown
physiolog
patholog
signific
mani
studi
demonstr
ahr
activ
immunostimul
inflamm
gener
exert
immunosuppress
effect
via
multipl
mechan
ahr
activ
chemic
agonist
shown
influenc
differenti
cytokinechemokin
product
cell
dendrit
cell
macrophag
ahr
also
shown
bind
modul
transcript
specif
multipl
experiment
set
could
contribut
cytokin
modul
studi
shown
ahr
activ
immun
cell
driven
result
positivefeedback
loop
help
establish
immunotoler
contrast
less
known
role
ahr
viru
infect
previou
work
explor
pathway
affect
ahr
activ
influenza
viru
iav
herp
simplex
viru
hsv
hepat
c
viru
hcv
epsteinbarr
viru
ebv
infect
virolog
impact
ahr
still
larg
uncharacter
show
cov
replic
macrophag
result
ahr
activ
manner
lead
increas
express
sever
downstream
effector
modul
cytokin
respons
also
show
tiparp
induc
ahr
provir
factor
covinfect
cell
infect
bonemarrowderiv
macrophag
bmdm
neurotrop
jhm
strain
mhv
mhvjhm
result
increas
express
sever
ifniinduc
parp
howev
tiparp
also
induc
mhvjhm
infect
bmdm
suggest
factor
besid
ifni
mediat
tiparp
upregul
infect
expand
result
infect
delay
brain
tumor
dbt
astrocytoma
cell
fig
fibroblastlik
cell
fig
minim
produc
ifn
mhv
infect
strain
mhv
use
replic
higher
titer
mhvjhm
vitro
upregul
parp
includ
lost
attenu
cell
line
infect
contrast
robust
parp
upregul
profil
seen
wildtyp
wt
bmdm
fig
despit
diminish
express
mani
ifndepend
parp
tiparp
highli
upregul
follow
infect
three
cell
type
suggest
conserv
mechan
induct
furthermor
induct
tiparp
bmdm
conserv
infect
consist
previou
find
mhvjhm
fig
although
studi
also
upregul
infect
cell
overal
result
indic
tiparp
upregul
anoth
pathway
infect
absenc
ifni
signal
previous
note
viral
genom
rna
grna
level
mhvjhm
infect
reduc
bmdm
treat
small
interf
rna
sirna
direct
toward
tiparp
confirm
phenotyp
treat
bmdm
tiparpspecif
sirna
prior
infect
low
pfucel
high
pfucel
multipl
infect
moi
measur
replic
quantif
viral
genom
content
infecti
viru
fig
low
moi
h
postinfect
hpi
tiparp
knockdown
decreas
viral
grna
level
fig
titer
fig
though
former
trend
toward
statist
signific
mhv
infect
moi
pfucel
show
significantli
decreas
grna
level
viru
titer
tiparp
knockdown
cell
fig
indic
role
tiparp
facilit
infect
differ
grna
viru
titer
persist
even
later
time
point
pi
cell
viabil
decreas
result
decreas
infectiousviru
titer
furthermor
mrna
level
unaffect
tiparp
defici
low
high
moi
hpi
increas
hpi
fig
c
togeth
result
suggest
tiparp
augment
mhv
replic
throughout
infect
neg
regul
ifni
express
later
stage
infect
express
tiparp
well
establish
induc
ligandactiv
ahr
hypothes
infect
result
ahr
activ
assess
ahr
activ
infect
bmdm
multipl
time
point
quantifi
mrna
express
known
effector
downstream
ahr
includ
tiparp
ahrr
fig
also
analyz
gene
express
ahr
ahr
ligandproduc
enzym
tdo
gene
express
also
induc
ahr
activ
found
mrna
undetect
time
point
ahrr
tiparp
ahr
mrna
upregul
cours
infect
fig
determin
respons
conserv
immun
cell
type
quantifi
transcript
downstream
effector
bone
marrowderiv
dendrit
cell
bmdc
fig
hpi
ahrr
tiparp
ahr
upregul
bmdc
suggest
ahr
activ
occur
follow
infect
multipl
cell
type
determin
vitro
result
could
recapitul
vivo
infect
mice
via
intraperiton
inject
fig
day
postinfect
dpi
level
tiparp
ahrr
mrna
increas
liver
infect
mice
suggest
mhv
elicit
ahr
activ
furthermor
upregul
downstream
gene
parallel
viral
replic
dpi
assess
measur
viral
grna
level
contrast
result
bmdm
mrna
detect
liver
sampl
modestli
increas
dpi
consist
result
obtain
use
infect
liver
level
ahr
activ
correl
viru
replic
bmdm
downstream
effector
mrna
level
less
upregul
cell
infect
lower
moi
fig
addit
uvinactiv
viru
infect
unabl
induc
express
ahr
downstream
effector
indic
ahr
activ
mhv
infect
complet
depend
viral
replic
fig
examin
whether
ahr
activ
altern
factor
facilit
express
downstream
effector
infect
cell
follow
chemic
inhibit
ahr
fig
opt
treatment
welldescrib
chemic
inhibitor
prevent
ligand
bind
ahr
fig
inhibit
receptor
estrogen
receptor
first
confirm
inhibit
chemic
ahr
activ
agonist
tcdd
bmdm
without
alter
cell
viabil
fig
c
infect
ahr
inhibitor
treatment
result
dosedepend
attenu
ahrr
surprisingli
tiparp
induct
diminish
concentr
inhibitor
furthermor
treatment
actual
increas
ahr
mrna
level
slightli
hpi
effect
grna
level
indic
reduct
downstream
effector
express
due
inhibit
ahr
activ
rather
decreas
ahr
express
increas
viru
replic
complement
result
determin
concurr
chemic
activ
infect
could
activ
ahr
treat
bmdm
tcdd
quantifi
induct
downstream
effector
gene
attenu
ahr
inhibit
fig
confirm
tcdd
affect
cell
viabil
fig
found
agonist
treatment
increas
express
ahrr
compar
vehicl
treatment
mock
mhvinfect
bmdm
tiparp
mrna
increas
follow
tcdd
treatment
uninfect
cell
margin
infect
requir
infect
express
potenti
tcdd
hpi
final
tcdd
treatment
without
infect
result
small
decreas
ahr
express
mock
mhvinfect
cell
hpi
affect
grna
level
suggest
agonistinduc
chang
downstream
effector
express
due
primarili
ahr
activ
tiparp
express
induc
ahr
agonist
treatment
fig
chang
follow
inhibitor
treatment
infect
fig
suggest
mhv
could
also
induc
tiparp
express
ahrindepend
mechan
ifni
treatment
bmdm
induc
tiparp
express
next
examin
whether
ifni
upregul
tiparp
express
inhibit
ahr
activ
use
mhvinfect
bmdm
treat
observ
dosedepend
decreas
express
ahrr
fig
confirm
ahr
activ
requir
ifn
signal
addit
ahr
inhibitor
treatment
reduc
tiparp
induct
bmdm
indic
ahr
ifni
compensatori
induc
tiparp
infect
howev
reduct
tiparp
mrna
level
bmdm
less
ahrr
suggest
addit
yet
unknown
factor
modul
express
final
grna
level
bmdm
trend
toward
modest
reduct
follow
ahr
inhibit
p
possibl
reflect
decreas
tiparp
express
taken
togeth
data
show
mhvinduc
ahr
activ
respons
upregul
ahrr
ifnreplet
defici
cell
tiparp
absenc
ifni
signal
result
indic
ahr
activ
infect
modul
downstream
express
fig
also
act
upstream
regul
ahr
catabol
tryptophan
ahr
ligand
kynurenin
fig
determin
role
ahr
activ
infect
infect
bmdm
quantifi
effector
mrna
level
fig
interestingli
level
ahrr
tiparp
ahr
grna
equival
follow
infect
wt
bmdm
expect
mrna
detect
defici
cell
rule
compensatori
effect
enzym
known
produc
kynurenin
also
assess
cell
mrna
could
detect
neither
wt
bmdm
togeth
result
suggest
infect
bmdm
elicit
ahr
activ
pathway
independ
ahr
activ
induc
modul
cytokinechemokin
product
innat
immun
respons
determin
whether
ahr
activ
cov
infect
modul
cytokin
express
infect
bmdm
quantifi
level
mrna
cytokin
previous
shown
regul
lipopolysaccharid
lp
induc
ahr
activ
macrophag
tumor
necrosi
factor
alpha
fig
inhibit
ahr
impact
express
mrna
hand
treatment
result
dosedepend
increas
level
mrna
concurr
decreas
level
mrna
ahr
could
activ
chemic
mean
infect
fig
substanti
find
treat
bmdm
tcdd
presenc
absenc
infect
low
high
moi
fig
consist
ahr
inhibitor
data
mrna
decreas
mrna
increas
concurr
chemic
activ
ahr
summari
result
indic
ahr
activ
modul
multipl
cytokin
express
level
infect
show
mhv
infect
activ
ahr
result
upregul
multipl
downstream
effector
gene
includ
ahrr
gene
infect
bmdm
bmdc
mous
liver
fig
also
demonstr
anoth
ahr
downstream
effector
tiparp
provir
role
mhv
replic
genom
rna
level
viru
titer
decreas
follow
tiparp
knockdown
fig
tiparp
induct
multifactori
sinc
ifni
treatment
induc
tiparp
express
bmdm
tiparp
express
still
observ
cell
line
defici
ifn
express
bmdm
fig
result
show
ahr
activ
directli
induc
tiparp
express
tcdd
treatment
enhanc
tiparp
express
uninfect
cell
lesser
extent
infect
cell
fig
tiparp
induct
infect
sensit
chemic
ahr
inhibit
absenc
presenc
ifni
signal
wt
bmdm
fig
consist
redund
role
ahr
ifni
signal
tiparp
express
infect
despit
attenu
inhibitor
treatment
tiparp
express
infect
cell
still
induc
indic
factor
known
modul
tiparp
express
estrogen
receptor
glucocorticoid
receptor
signal
pathway
could
also
impact
express
cov
infect
addit
decreas
replic
tiparp
knockdown
also
result
increas
mrna
express
fig
howev
viral
genom
rna
level
reduc
tiparp
knockdown
cell
earli
hpi
ifni
mrna
level
increas
studi
requir
establish
causal
relationship
effect
tiparp
ifni
express
replic
result
align
previou
studi
show
iav
infect
tiparp
adp
ribosyl
result
increas
replic
reduc
ifni
level
howev
tiparp
also
shown
bind
sindbi
viru
rna
trigger
antivir
host
respons
therefor
import
determin
whether
tiparp
facilit
mhv
replic
depend
adpribosyl
andor
rnabind
activ
contrast
tiparp
upregul
downstream
effector
ahrr
infect
driven
primarili
ahr
activ
evidenc
fact
express
effector
enhanc
ahr
agonist
attenu
dosedepend
manner
ahrspecif
inhibitor
fig
ahr
activ
studi
immun
cell
follow
agonist
immunostimul
treatment
role
context
viru
infect
rel
understudi
studi
detail
host
pathway
affect
ahr
activ
ebv
encod
viral
protein
bind
arnt
enhanc
transactiv
downstream
effector
ahr
ahr
facilit
hcv
infect
induc
express
cyp
aid
format
lipid
droplet
requir
viru
product
mention
ahr
function
provir
manner
iav
infect
induc
tiparp
contrast
ahr
activ
hsv
hivinfect
macrophag
restrict
replic
inhibit
express
cyclin
cyclindepend
kinas
thu
ahr
activ
viral
infect
differ
effect
modul
multipl
cellular
pathway
mani
remain
uncharacter
surprisingli
ahr
thought
activ
primarili
kynurenin
synthes
via
inflammatori
state
drive
positivefeedback
cycl
immun
cell
result
demonstr
mhv
infect
activ
ahr
independ
fig
detect
gene
express
infect
murin
liver
sampl
fig
consist
notion
tdo
larg
confin
liver
tdo
could
drive
ahr
activ
produc
kynurenin
vivo
infect
tdo
mrna
undetect
bmdm
suggest
kynurenin
produc
novel
pathway
bmdm
cell
util
kynurenin
primari
ahr
ligand
cov
infect
ahr
activ
sever
biochem
speci
includ
metabolit
tryptophan
bilirubin
metabolit
uncharacter
biosynthet
pathway
potenti
initi
pathway
includ
prostaglandin
synthesi
camp
product
gener
oxid
stress
altern
infect
host
viral
protein
could
directli
bind
ahr
enhanc
transactiv
activ
manner
similar
ebvencod
though
may
still
requir
concomit
ligand
bind
nonetheless
level
ligand
bind
partner
activ
ahr
bmdm
would
like
scale
replic
downstream
effector
transcript
correl
viru
load
fig
addit
investig
necessari
detail
exact
mechan
idoindepend
ahr
activ
pathway
furthermor
regul
ahr
activ
mhv
infect
bmdm
could
still
modul
cellular
pathway
part
host
respons
instanc
shown
regul
immun
cell
function
mediat
tryptophan
starvat
result
activ
mtor
mediat
sever
metabol
immun
pathway
final
chemic
activ
inhibit
ahr
infect
result
chang
mrna
level
multipl
cytokin
fig
suggest
ahr
function
modul
cytokin
respons
mhv
infect
specif
ahr
neg
regul
posit
regul
cytokin
also
upregul
brain
mhvinfect
mice
chang
due
alter
viral
replic
viral
load
unchang
ahr
activ
inhibit
mechan
drive
cytokin
chang
mhv
infect
like
complex
probabl
involv
interact
activ
ahr
fig
effect
cytokin
express
chang
need
investig
vivo
determin
role
pathogenesi
function
protean
cytokin
addit
posttranscript
regul
activ
ligand
may
differ
cultur
bmdm
versu
infect
mice
thu
difficult
conclud
present
ahr
drive
strictli
pro
antiinflammatori
phenotyp
rather
ahr
activ
may
serv
fine
tune
innat
immun
respons
mhv
infect
pathogenfre
wt
mice
purchas
jackson
laboratori
mice
obtain
gener
gift
mark
santillan
univers
iowa
iowa
citi
ia
mice
bred
maintain
anim
care
facil
univers
iowa
approv
univers
iowa
institut
anim
care
use
committe
iacuc
follow
guidelin
set
forth
guid
care
use
laboratori
anim
dbt
cell
cell
hela
cell
express
mhv
receptor
carcinoembryon
antigenrel
cell
adhes
molecul
helamhvr
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
uml
penicillin
streptomycin
bone
marrow
cell
obtain
wt
mice
differenti
macrophag
bmdm
incub
cell
cell
supernat
fb
rpmi
medium
day
bmdm
wash
replac
fresh
medium
everi
day
day
bone
marrow
cell
obtain
wt
mice
differenti
dendrit
cell
bmdc
incub
granulocytemacrophag
colonystimul
factor
gmcsf
extra
medium
ad
day
refresh
cell
medium
complet
chang
day
cell
use
infect
day
propag
cell
manner
describ
previous
bmdm
infect
viru
indic
moi
adsorpt
phase
indic
time
point
cell
lyse
trizol
rna
isol
cell
frozen
supernat
determin
titer
hela
cell
gener
replicationdefici
viru
stock
uv
inactiv
use
biosafeti
cabinet
uv
lamp
min
room
temperatur
inactiv
confirm
plaqu
assay
ahr
agonist
studi
medium
nm
tcdd
ad
mock
adsorpt
adsorpt
chemic
inhibitor
studi
bmdm
pretreat
sigmaaldrich
vehicl
dimethyl
sulfoxid
dmso
h
prior
infect
treatment
nm
tcdd
tcdd
treatment
infect
medium
contain
inhibitor
ad
back
cell
mous
infect
mice
anesthet
ketaminexylazin
inocul
intraperiton
pfu
dmem
mock
infect
dmem
mice
sacrif
dpi
liver
harvest
store
trizol
thermo
fisher
scientif
bmdm
transfect
pmolml
sirna
virom
blue
lipocalyx
follow
manufactur
protocol
media
replac
h
transfect
cell
infect
h
posttransfect
sequenc
neg
nonspecif
control
dicersubstr
short
interf
rna
dsirna
follow
sens
cguuaaucgcguauaauacgcguat
antisens
auacgcguauuauacgcgauuaacgac
sequenc
dsirna
oligonucleotid
direct
toward
tiparp
integr
dna
technolog
idt
follow
sens
gaagauaaaaguuaucgaaucautt
antisens
aaaugauucgauaacuuuuaucuucug
rna
purifi
use
trizol
thermo
fisher
scientif
directzol
column
zymo
research
phase
separ
instruct
manufactur
cdna
synthes
use
moloney
murin
leukemia
viru
mmlv
revers
transcriptas
thermo
fisher
scientif
quantifi
realtim
thermocycl
use
powerup
sybr
green
master
mix
thermo
fisher
scientif
realtim
quantit
pcr
rtqpcr
primer
list
tabl
primer
span
exonexon
junction
possibl
avoid
quantif
residu
genom
dna
control
without
revers
transcriptas
also
analyz
confirm
absenc
contamin
dna
target
gene
normal
housekeep
gene
hypoxanthineguanin
phosphoribosyltransferas
hprt
follow
equat
ct
gene
interest
ct
hprt
ct
threshold
cycl
result
shown
ratio
hprt
calcul
viabilitymetabol
bmdm
treat
nm
tcdd
h
assess
use
vybrant
bromid
mtt
cell
prolifer
assay
thermo
fisher
scientif
accord
manufactur
instruct
cell
viabil
measur
absorb
nm
unpair
twotail
student
test
use
determin
statist
signific
differ
mean
group
graph
show
mean
standard
error
mean
sem
n
valu
repres
number
biolog
replic
figur
multipl
trial
combin
singl
figur
express
valu
titer
compar
signific
p
valu
annot
p
valu
less
greater
numer
valu
list
graph
bar
consid
trend
toward
signific
